Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Asthma
100%
Airway
100%
Fluticasone Propionate
100%
Mucosal Blood Flow
100%
Montelukast
100%
Forced Expiratory Volume in 1 Second (FEV1)
28%
Treatment Period
28%
No Significant Difference
14%
Airway Inflammation
14%
Mild Asthma
14%
Persistent Asthma
14%
Vascular Effects
14%
Anti-inflammatory Agents
14%
Physiological Dead Space
14%
Vmax
14%
Washout Period
14%
Airway Function
14%
Airway Blood Flow
14%
Medicine and Dentistry
Asthma
100%
Blood Flow
100%
Montelukast
100%
Fluticasone Propionate
100%
Respiratory Tract Inflammation
14%
Scanning Electron Microscopy
14%
Antiinflammatory Agent
14%
Lung Dead Space
14%
Mild Intermittent Asthma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Fluticasone Propionate
100%
Montelukast
100%
Respiratory Tract Inflammation
14%
Antiinflammatory Agent
14%
Scanning Electron Microscopy
14%
Mild Intermittent Asthma
14%
Agricultural and Biological Sciences
Blood Flow
100%
Airway
100%
Fluticasone Propionate
100%
Scanning Electron Microscopy
14%
Antiinflammatory
14%